Literature DB >> 6424170

Intravenous drug users and the acquired immune deficiency syndrome.

H M Ginzburg.   

Abstract

Acquired immune deficiency syndrome (AIDS), a new epidemic disease characterized by dysfunction of cellular immunity, is most common among homosexual and bisexual males with multiple sexual partners and users of intravenous drugs. AIDS appears to be spread by contact with blood products and body fluids. Not only is the heroin user at increased risk of contracting AIDS, but also the occasional recreational drug user who shares a needle and syringe when he or she self-administers cocaine or amphetamines at a party on a weekend. Although precise figures are not available, there may be as many as several million recreational and regular users of cocaine and heroin. Data from a national sample of drug abuse treatment programs indicates that more than 80 percent of all clients seeking treatment, whatever their primary drug of abuse at the time of admission to treatment, have administered drugs to themselves intravenously during the year before treatment. Several hundred thousand treatment episodes occur each year. Data from surveys indicate that drug users entering treatment are well aware of the increased risks associated with AIDS. It is not surprising that treatment staff, also, have expressed concerns about their own susceptibility to the disease. Special education programs for these health workers have been instituted in New York City and have met with success. These programs have provided information and reassurance to treatment providers. At present, no health worker providing direct treatment service to drug abusers with a history of intravenous drug use has contracted AIDS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424170      PMCID: PMC1424536     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  8 in total

1.  Heroin addiction in the suburbs--an epidemiologic study.

Authors:  R Levengood; P Lowinger; K Schooff
Journal:  Am J Public Health       Date:  1973-03       Impact factor: 9.308

2.  Infection-control guidelines for patients with the acquired immunodeficiency syndrome (AIDS).

Authors:  J E Conte; W K Hadley; M Sande
Journal:  N Engl J Med       Date:  1983-09-22       Impact factor: 91.245

3.  Acquired immunodeficiency syndrome in a patient with hemophilia.

Authors:  K C Davis; C R Horsburgh; U Hasiba; A L Schocket; C H Kirkpatrick
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

4.  An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction.

Authors:  H Masur; M A Michelis; J B Greene; I Onorato; R A Stouwe; R S Holzman; G Wormser; L Brettman; M Lange; H W Murray; S Cunningham-Rundles
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

5.  Clinical depression among narcotic addicts maintained on methadone in the community.

Authors:  M M Weissman; F Slobetz; B Prusoff; M Mezritz; P Howard
Journal:  Am J Psychiatry       Date:  1976-12       Impact factor: 18.112

6.  Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome.

Authors:  C Harris; C B Small; R S Klein; G H Friedland; B Moll; E E Emeson; I Spigland; N H Steigbigel
Journal:  N Engl J Med       Date:  1983-05-19       Impact factor: 91.245

7.  Acquired immunodeficiency syndrome in male prisoners. New insights into an emerging syndrome.

Authors:  G P Wormser; L B Krupp; J P Hanrahan; G Gavis; T J Spira; S Cunningham-Rundles
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

8.  Immune deficiency syndrome in children.

Authors:  J Oleske; A Minnefor; R Cooper; K Thomas; A dela Cruz; H Ahdieh; I Guerrero; V V Joshi; F Desposito
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

  8 in total
  9 in total

Review 1.  Drug treatment as HIV prevention: a research update.

Authors:  David S Metzger; George E Woody; Charles P O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

Review 2.  AIDS in New York City: the role of intravenous drug users.

Authors:  A Ron; D E Rogers
Journal:  Bull N Y Acad Med       Date:  1989-09

3.  Screening prospective blood donors for AIDS risk factors: will sufficient donors be found?

Authors:  D I Gregorio; J V Linden
Journal:  Am J Public Health       Date:  1988-11       Impact factor: 9.308

Review 4.  The role of naltrexone in the management of drug abuse.

Authors:  H M Ginzburg; M G MacDonald
Journal:  Med Toxicol       Date:  1987 Mar-Apr

5.  Drug users' AIDS-related knowledge, attitudes, and behaviors before and after AIDS education sessions.

Authors:  L Dengelegi; J Weber; S Torquato
Journal:  Public Health Rep       Date:  1990 Sep-Oct       Impact factor: 2.792

6.  HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a North-German drug clinic.

Authors:  G Paschelke; G Altvater-Kremer; W D Meyer; H Kremer
Journal:  Klin Wochenschr       Date:  1987-01-05

7.  HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack.

Authors:  R E Booth; J K Watters; D D Chitwood
Journal:  Am J Public Health       Date:  1993-08       Impact factor: 9.308

8.  Drug use patterns: implications for the acquired immunodeficiency syndrome.

Authors:  L S Brown; R Evans; D Murphy; B J Primm
Journal:  J Natl Med Assoc       Date:  1986-12       Impact factor: 1.798

Review 9.  Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU).

Authors:  R T D'Aquila; A B Williams
Journal:  Yale J Biol Med       Date:  1987 Nov-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.